Cannabis firm Organigram rises on Q2 profit, revenue jump

U.S.-listed shares of pot firm Organigram OGI.TO, OGI.N rise 10.2% to $1.3 premarket

Company posts Q2 profit and a jump in revenue on higher international sales and contributions from its Motif acquisition

Company posts Q2 net income of $42.5 million compared with a loss of $27.1 million a year ago

Q2 gross revenue rises to $102.8 million, up 79% from a year ago

As of last close, shares are down 28.7% YTD